Effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis

We investigated the effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis for 3 and 5 years. Significant improvement found the decrease of the frequency of clinical exacerbations and delay the accumulation of physical disability during treatment period.

Bibliografische gegevens
Hoofdauteurs: V. M. Alifirova, M. A. Titova, A. A. Vereschaka
Formaat: Artikel
Taal:English
Gepubliceerd in: Siberian State Medical University (Tomsk) 2010-08-01
Reeks:Бюллетень сибирской медицины
Onderwerpen:
Online toegang:https://bulletin.ssmu.ru/jour/article/view/1618
_version_ 1827991793329766400
author V. M. Alifirova
M. A. Titova
A. A. Vereschaka
author_facet V. M. Alifirova
M. A. Titova
A. A. Vereschaka
author_sort V. M. Alifirova
collection DOAJ
description We investigated the effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis for 3 and 5 years. Significant improvement found the decrease of the frequency of clinical exacerbations and delay the accumulation of physical disability during treatment period.
first_indexed 2024-04-10T01:10:50Z
format Article
id doaj.art-6642ea2d901b4e038c4360dce6d849c5
institution Directory Open Access Journal
issn 1682-0363
1819-3684
language English
last_indexed 2024-04-10T01:10:50Z
publishDate 2010-08-01
publisher Siberian State Medical University (Tomsk)
record_format Article
series Бюллетень сибирской медицины
spelling doaj.art-6642ea2d901b4e038c4360dce6d849c52023-03-13T09:58:13ZengSiberian State Medical University (Tomsk)Бюллетень сибирской медицины1682-03631819-36842010-08-0194192210.20538/1682-0363-2010-4-19-221121Effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosisV. M. Alifirova0M. A. Titova1A. A. Vereschaka2Сибирский государственный медицинский университетСибирский государственный медицинский университетСибирский государственный медицинский университетWe investigated the effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis for 3 and 5 years. Significant improvement found the decrease of the frequency of clinical exacerbations and delay the accumulation of physical disability during treatment period.https://bulletin.ssmu.ru/jour/article/view/1618рассеянный склерозчастота обостренийбалл edss
spellingShingle V. M. Alifirova
M. A. Titova
A. A. Vereschaka
Effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis
Бюллетень сибирской медицины
рассеянный склероз
частота обострений
балл edss
title Effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis
title_full Effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis
title_fullStr Effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis
title_full_unstemmed Effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis
title_short Effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis
title_sort effectiveness of copaxone in patients with relapsing remitting multiple sclerosis
topic рассеянный склероз
частота обострений
балл edss
url https://bulletin.ssmu.ru/jour/article/view/1618
work_keys_str_mv AT vmalifirova effectivenessofcopaxoneinpatientswithrelapsingremittingmultiplesclerosis
AT matitova effectivenessofcopaxoneinpatientswithrelapsingremittingmultiplesclerosis
AT aavereschaka effectivenessofcopaxoneinpatientswithrelapsingremittingmultiplesclerosis